Search - tctmd.com

Displaying 381 - 400 of 4854

Sort: Relevancy | Date

Presentation TCT 2024

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

The Body of Evidence: Safety, Efficacy and Sustainability of rf RDN

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

Setting the Standard: Patient Selection &the Safe and Effective Use of RDN

Presenter: Tai Kobayashi

October 28, 2024

Presentation TCT 2024

RDN Care Pathway Development

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Hypertension State of Union and Role of RDN

Presenter: Roxana Mehran

October 28, 2024

Presentation TCT 2024

Case Examples and Outcomes

Presenter: Tai Kobayashi

October 28, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

Presentation TCT 2024

Digital Era in Dermatology with Noninvasive Virtual Skin Biopsies (Enspectra Health) (69301)

Presenter: Gabriel Sanchez

October 27, 2024

Presentation TCT 2024

Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials

Presenter: C. Michael Gibson

October 27, 2024

Presentation TCT 2024

How Great if True: My Futuristic View in How GLP-1 Agonist Will Continue Expanding Its Therapeutic Reach

Presenter: Marc Bonaca

October 27, 2024

News Daily News

Michelle Tarver Named New FDA Director of Medical Devices

L.A. McKeown

October 25, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

The Cardiovascular Consequences of War

Todd Neale

October 23, 2024

News Daily News

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

L.A. McKeown

October 22, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

Todd Neale

October 21, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

Advertisement

TCT 481: Renal Artery Imaging Through Long-Term Follow-Up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

The Body of Evidence: Safety, Efficacy and Sustainability of rf RDN

Setting the Standard: Patient Selection &the Safe and Effective Use of RDN

RDN Care Pathway Development

Hypertension State of Union and Role of RDN

Case Examples and Outcomes

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

Digital Era in Dermatology with Noninvasive Virtual Skin Biopsies (Enspectra Health) (69301)

Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials

How Great if True: My Futuristic View in How GLP-1 Agonist Will Continue Expanding Its Therapeutic Reach

Michelle Tarver Named New FDA Director of Medical Devices

October 2024 Dispatch for the CV Team

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

The Cardiovascular Consequences of War

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

What’s Going to Be Big at TCT 2024?

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content